Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

miR-466a Targeting of TGF-β2 Contributes to FoxP3+ Regulatory T Cell Differentiation in a Murine Model of Allogeneic Transplantation.

Becker W, Nagarkatti M, Nagarkatti PS.

Front Immunol. 2018 Apr 9;9:688. doi: 10.3389/fimmu.2018.00688. eCollection 2018.

2.

Mortality risk after cancer diagnosis in kidney transplant recipients: the limitations of analyzing hospital administration data alone.

Jackson-Spence F, Gillott H, Tahir S, Nath J, Mytton J, Evison F, Sharif A.

Cancer Med. 2018 Mar;7(3):931-939. doi: 10.1002/cam4.1367. Epub 2018 Feb 14.

3.

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.

Storey BC, Staplin N, Harper CH, Haynes R, Winearls CG, Goldacre R, Emberson JR, Goldacre MJ, Baigent C, Landray MJ, Herrington WG.

Kidney Int. 2018 May;93(5):1165-1174. doi: 10.1016/j.kint.2017.11.020. Epub 2018 Feb 12.

4.

Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report.

Paoletti M, Cattadori B, Gregorini M, Viglio A, Gentile G, D'Armini AM, Pellegrini C, La Fianza A.

CEN Case Rep. 2018 May;7(1):132-136. doi: 10.1007/s13730-018-0310-9. Epub 2018 Jan 31.

5.

Process and barriers to organ donation and causes of brain death in northeast of Iran.

Bahrami A, Khaleghi E, Vakilzadeh AK, Afzalaghaee M.

Electron Physician. 2017 Feb 25;9(2):3797-3802. doi: 10.19082/3797. eCollection 2017 Feb.

6.

Urothelial carcinoma of donor origin in a kidney transplant patient.

Michel Ortega RM, Wolff DJ, Schandl CA, Drabkin HA.

J Immunother Cancer. 2016 Oct 18;4:63. eCollection 2016.

7.

A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.

Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gómez-Vaquero C, Polo C, Revuelta I, Francos J, Torras J, García-Barrasa A, Bestard O, Grinyó JM.

J Am Soc Nephrol. 2016 Aug;27(8):2487-94. doi: 10.1681/ASN.2015060622. Epub 2015 Dec 8.

8.

Haematuria in postrenal transplant patients.

Wang Z, Vathsala A, Tiong HY.

Biomed Res Int. 2015;2015:292034. doi: 10.1155/2015/292034. Epub 2015 Mar 30. Review.

9.

Longitudinal analysis of whole blood transcriptomes to explore molecular signatures associated with acute renal allograft rejection.

Shin H, Günther O, Hollander Z, Wilson-McManus JE, Ng RT, Balshaw R, Keown PA, McMaster R, McManus BM, Isbel NM, Knoll G, Tebbutt SJ.

Bioinform Biol Insights. 2014 Jan 22;8:17-33. doi: 10.4137/BBI.S13376.. eCollection 2014.

10.

Awareness and attitudes towards face and organ transplant in Kumasi, Ghana.

Agbenorku P, Agbenorku M, Agamah G.

Ghana Med J. 2013 Mar;47(1):30-4.

11.

Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Hecking M, Werzowa J, Haidinger M, Hörl WH, Pascual J, Budde K, Luan FL, Ojo A, de Vries AP, Porrini E, Pacini G, Port FK, Sharif A, Säemann MD; European-New-Onset Diabetes After Transplantation Working Group.

Nephrol Dial Transplant. 2013 Mar;28(3):550-66. doi: 10.1093/ndt/gfs583. Epub 2013 Jan 17.

12.

Do cannabinoids have a therapeutic role in transplantation?

Nagarkatti M, Rieder SA, Hegde VL, Kanada S, Nagarkatti P.

Trends Pharmacol Sci. 2010 Aug;31(8):345-50. doi: 10.1016/j.tips.2010.05.006. Epub 2010 Jun 28. Review.

13.

Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy.

Suthanthiran M, Hojo M, Maluccio M, Boffa DJ, Luan FL.

Trans Am Clin Climatol Assoc. 2009;120:369-88.

14.

A descriptive analysis of 1251 solid organ transplant visits to the emergency department.

Unterman S, Zimmerman M, Tyo C, Sterk E, Gehm L, Edison M, Benedetti E, Orsay E.

West J Emerg Med. 2009 Feb;10(1):48-54.

15.

MicroRNA expression profiles predictive of human renal allograft status.

Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M.

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5330-5. doi: 10.1073/pnas.0813121106. Epub 2009 Mar 16.

16.

Nanomedicines in renal transplant rejection--focus on sirolimus.

Shen LJ, Wu FL.

Int J Nanomedicine. 2007;2(1):25-32. Review.

Supplemental Content

Support Center